Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast.
about
Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to GoRationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategyCancer-associated fibroblasts in digestive tumorsFibroblast activation protein α in tumor microenvironment: recent progression and implications (review)FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer.FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy.FOXP3 expression and clinical characteristics of hepatocellular carcinomaFibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.Activation of EDTA-resistant gelatinases in malignant human tumors.Prognostic stromal gene signatures in breast cancer.Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterationsFibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinomaTargeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxinClinical implications and characteristics of factor forkhead box protein 3 in gastric cancer.Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells.Fibroblast activation protein: A potential therapeutic target in cancer.Dipeptidyl peptidase-IV and related molecules: markers of malignancy?Inflammatory fibroblasts in cancer.Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics.Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications.DPPIV/CD26: a tumor suppressor or a marker of malignancy?Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model.The expression of proline-specific enzymes in the human lungExpression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma.Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.
P2860
Q26772925-2730674E-0C1F-4352-8914-96FC7DF89680Q27004215-1FAB810B-14B1-4DE5-B6EB-1FD1FEAC1180Q27022816-3AB628FB-DF4C-42A7-A258-4ECBF44F323FQ28082504-8F25EE61-3847-4535-92CE-B2F68433B8F5Q31018027-AD9791CE-C36A-4DA6-9829-DAC4B3600608Q33511204-B5665CC8-A282-4215-A6DE-A0645165B399Q33773960-5DF41CFF-48E9-45A3-9086-E1C9BABA553FQ34115941-C6BE4B14-8B7B-4C4B-80CB-8FF3BE7344E6Q34333197-8E5E12B4-7786-4649-BBE3-FAC0765F2802Q34816275-2414A4A8-036F-4563-9574-4CC0C0BD3ED2Q35113892-98AB9A76-81E2-4492-B923-FE08BFD983C3Q35180291-C5B2377B-0C2E-4BA8-9C54-E69E9ED85E14Q35182174-C33755F6-8E5D-4653-8EEE-14EABA56CF50Q35666119-A995B925-439A-4E44-872C-C837746EB6DDQ35739745-DBE3CD33-4695-426D-904E-063990D4018CQ35754294-D6DA5AF9-9471-4E38-838B-C2547F5D5DA5Q35761855-B3A01827-8986-4947-B813-CB67A9989B78Q35803483-B5E2E5F5-5592-40A6-9680-DD6793D2CD8CQ35947656-39740310-E396-4B86-A128-1959A03D9F23Q36230689-1BDA0B59-D826-4F52-9B66-4E8839C3FB03Q36486772-3250281E-4F1B-41EC-818C-1EE3B48775F0Q36695058-2BE4E1B2-8238-44D2-A574-5315126220F8Q37003883-6B79194D-A404-42B6-8674-9E83175D0109Q37441669-FF4A414A-1393-4C5D-8B16-A56BC0C38067Q37726232-A8007A88-0497-475B-92DD-1CB445DF2D90Q37975053-8FFBC80D-413C-4D39-B9CD-7FEC6AAF6E5DQ38089765-A9892262-B809-427A-8B38-D519574D1D56Q38412911-5203D64C-8FA6-495D-B441-B870E95DA34AQ38563910-84579CCC-9A90-41AA-AF4A-D171E9D00BABQ38704824-755CA7C7-DD78-446D-A2D7-DBB13A7340E4Q38760903-1314B020-F244-4AC5-87DB-9751B1184E90Q38761102-9066E9C6-FA30-4757-95D7-FED83E04AFFCQ38809929-4F113045-D41C-44DA-AD73-C37355781446Q39018781-39325185-7885-479F-9894-71F977E69124Q39377477-FE17DE7B-0DB3-4435-AA67-98FAAE335D69Q39500859-CBC643EC-A1F0-412B-BAC3-9956DC45367BQ39538239-8E4A4712-2482-4FB3-9C12-82394115AF1CQ39599536-F3B0BAC4-44F2-44C3-896C-84BA3FB86D65Q41512848-0B26DAED-90CD-446F-AE30-0E641BADCF91Q42455197-EB7CE2D8-7464-4D97-BC69-C3C77A0C72AA
P2860
Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@ast
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@en
type
label
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@ast
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@en
prefLabel
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@ast
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@en
P2093
P2860
P1476
Stromal expression of fibrobla ...... ve ductal carcinoma of breast.
@en
P2093
P2860
P356
10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U
P577
2001-01-01T00:00:00Z